The FDA has announced that specific type of Insulin pumps can be controlled by a hacker to alter the settings of the pump. As the FDA puts it:
This could allow a person to over deliver insulin to a patient, leading to low blood sugar (hypoglycemia), or to stop insulin delivery, leading to high blood sugar and diabetic ketoacidosis (a buildup of acids in the blood).
FDA
cybersqueeze 